New discoveries in the field of non-coding RNA research have led to an increased focus on understanding the role of the “Dark Genome” in cancer. Of particular interest are long non-coding RNAs, which regulate gene expression, show tissue specificity, and are deregulated in several human cancers. Newly emerging as a potential source of prognostic biomarkers, they may also aid in the early detection of disease. CHI’s Inaugural Long Non-Coding RNA in Cancer meeting will cover the exciting progress in this new frontier in genome biology.
- Long Non-Coding RNA in Cancer 2015